GRFS Grifols SA ADR

$9.97

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/2/2025

About Grifols SA ADR

Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.

Website: https://www.grifols.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1438569
Address
1585 BROADWAY, SUITE 2376, NEW YORK, NY, US
Valuation
Market Cap
$5.70B
P/E Ratio
27.23
PEG Ratio
0.23
Price to Book
0.72
Performance
EPS
$0.26
Dividend Yield
Profit Margin
2.18%
ROE
2.64%
Technicals
50D MA
$7.50
200D MA
$7.96
52W High
$9.96
52W Low
$5.79
Fundamentals
Shares Outstanding
258M
Target Price
$10.84
Beta
0.92

GRFS EPS Estimates vs Actual

Estimated
Actual

GRFS News & Sentiment

Sep 24, 2025 • Zacks Commentary BULLISH
GRFS or NBIX: Which Is the Better Value Stock Right Now?
GRFS vs. NBIX: Which Stock Is the Better Value Option?
Sep 24, 2025 • Zacks Commentary BULLISH
Should Value Investors Buy Grifols ( GRFS ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sep 08, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Should Value Investors Buy Grifols ( GRFS ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aug 28, 2025 • Zacks Commentary SOMEWHAT-BULLISH
All You Need to Know About Grifols ( GRFS ) Rating Upgrade to Buy
Grifols (GRFS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Aug 20, 2025 • Zacks Commentary BULLISH
GRFS or NBIX: Which Is the Better Value Stock Right Now?
GRFS vs. NBIX: Which Stock Is the Better Value Option?
Aug 20, 2025 • Zacks Commentary BULLISH
Are Investors Undervaluing Grifols ( GRFS ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sentiment Snapshot

Average Sentiment Score:

0.259
50 articles with scored sentiment

Overall Sentiment:

Bullish

GRFS Reported Earnings

Feb 26, 2025
Dec 31, 2024 (Pre market)
-0.12 Surprise
  • Reported EPS: $0.11
  • Estimate: $0.23
  • Whisper:
  • Surprise %: -52.7%
Nov 07, 2024
Sep 30, 2024 (Pre market)
-0.07 Surprise
  • Reported EPS: $0.17
  • Estimate: $0.24
  • Whisper:
  • Surprise %: -29.2%
Jul 30, 2024
Jun 30, 2024 (Post market)
-0.06 Surprise
  • Reported EPS: $0.15
  • Estimate: $0.21
  • Whisper:
  • Surprise %: -28.6%
May 16, 2024
Mar 31, 2024 (Post market)
-0.08 Surprise
  • Reported EPS: $0.07
  • Estimate: $0.15
  • Whisper:
  • Surprise %: -53.3%
Feb 29, 2024
Dec 31, 2023 (Pre market)
-0.08 Surprise
  • Reported EPS: $0.14
  • Estimate: $0.22
  • Whisper:
  • Surprise %: -36.4%
Nov 02, 2023
Sep 30, 2023 (Pre market)
-0.11 Surprise
  • Reported EPS: $0.11
  • Estimate: $0.22
  • Whisper:
  • Surprise %: -50.0%
Jul 27, 2023
Jun 30, 2023 (Pre market)
-0.03 Surprise
  • Reported EPS: $0.16
  • Estimate: $0.20
  • Whisper:
  • Surprise %: -17.2%
May 15, 2023
Mar 31, 2023 (Post market)
-0.12 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.16
  • Whisper:
  • Surprise %: -72.5%
Feb 28, 2023
Dec 31, 2022 (Pre market)
-0.09 Surprise
  • Reported EPS: $0.06
  • Estimate: $0.15
  • Whisper:
  • Surprise %: -57.6%

Financials